Shanth Goonewardene, MD
Associate Chief, Section of Gastrointestinal Pathology Director, Quality Assurance
Dr. Goonewardene received his MD from Jefferson Medical College. He completed his pathology residency and surgical pathology fellowship (with focus in Gastrointestinal Pathology) at Thomas Jefferson University Hospital, Philadelphia, Pa. He then completed a Fellowship in Cytopathology at the Hospital of the University of Pennsylvania, Philadelphia, Pa. He is certified by the American Board of Pathology in Anatomic and Clinical Pathology with added board certification in Cytopathology. Dr. Goonewardene serves as Director of the Anatomic Pathology Quality Assurance Committee at Lehigh Valley Health Network. His research and publications focus on gastrointestinal pathology. He is currently investigating the use of molecular markers in increasing the sensitivity of detecting pancreatic adenocarcinoma in fine needle aspiration cytology specimens. Dr. Shanth Goonewardene is a Clinical Assistant Professor at University of South Florida (USF), Morsani College of Medicine.
The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients t reated with surgery alone.
Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R.
Cancer. 2004 Jun 1;100(11):2317-27. PMID: 15160334 Free Article
Glucose transporter Glut-1 is of limited value for detecting breast carcinoma in serous effusions.
Zimmerman RL,Goonewardene S, Fogt F.
Mod Pathol. 2001 Aug;14(8):748-51. PMID:11504833 Free Article
Diagnostic utility of BCA-225 in detecting adenocarcinoma in serous effusions.
Zimmerman RL, Goonewardene S,Fogt F.
Anal Quant Cytol Histol. 2000 Oct;22(5):353-7. PMID:11064810
Diagnostic value of a second generation CA 15-3 antibody to detect adenocarcinoma in body cavity effusions.
Zimmerman RL, Fogt F, Goonewardene S.
Cancer. 2000 Aug 25;90(4):230-4. PMID:10966563